Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Interferon beta-1a shows promise against MS

People who received injections of the multiple sclerosis (MS) drug interferon beta-1a soon after their first signs of possible MS were less likely to progress to clinically definite MS than people who switched to interferon beta-1a from placebo, according to new phase three results of the three-year REFLEXION clinical trial that will be presented as part of the Emerging Science program at the American Academy of Neurology's 64th Annual Meeting in New Orleans, April 21 to April 28, 2012.

20 Apr 2012

Clinical study to evaluate high-dose vitamin D supplements for MS

Doctors at several centers across the U.S. are recruiting people who have multiple sclerosis (MS) to determine the effectiveness of high-dose vitamin D supplements for reducing MS disease activity.

20 Apr 2012

SBU to advance research and clinical care at National Pediatric MS Center

Stony Brook University has received a $2.5 million gift from Robert and Lisa Lourie to advance research and clinical care at the National Pediatric Multiple Sclerosis (MS) Center at Stony Brook Long Island Children's Hospital and to establish a new state-of-the-art imaging center at Stony Brook Medicine.

19 Apr 2012

Abbott reports positive results from LCIG Phase 3 trial for advanced Parkinson's disease

Abbott announced today the results from a Phase 3 trial evaluating the company's investigational compound for advanced Parkinson's disease, levodopa-carbidopa intestinal gel (LCIG).

18 Apr 2012

Levodopa-carbidopa intestinal gel better than standard oral form to treat advanced Parkinson's disease

A levodopa-carbidopa intestinal gel (LCIG) works better than standard oral levodopa-carbidopa in reducing "off" time in patients with advanced Parkinson's disease.

18 Apr 2012

Medgenics seeks IND approval to initiate EPODURE Biopump Phase IIb anemia study in ESRD patients

Medgenics, Inc., the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue, today announced that it has filed an Investigational New Drug application with the U.S. Food and Drug Administration to initiate a Phase IIb multi-center, 100-patient clinical trial.

18 Apr 2012

ONO-4641 reduces number of lesions in people with MS

An investigational oral drug called ONO-4641 reduced the number of lesions in people with multiple sclerosis (MS), according to the results of a phase two clinical trial to be presented as Emerging Science at the American Academy of Neurology's 64th Annual Meeting in New Orleans April 21 to April 28, 2012.

17 Apr 2012

Synthon receives tentative approval for tadalafil tablets

Synthon has announced that its subsidiary Synthon Pharmaceuticals, Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its abbreviated new drug application for tadalafil tablets, 20 mg on April 13, 2012. Synthon's product is a generic and bioequivalent version of Eli Lilly & Co and United Therapeutics’ Adcirca® tablets, which are indicated for the treatment of pulmonary arterial hypertension to improve exercise ability.

16 Apr 2012

TGF-β molecule ramps up the immune system in some cases and suppress it in others

Loyola researchers are reporting surprising findings about a molecule that helps ramp up the immune system in some cases and suppress it in others.

16 Apr 2012

New drug to detect beta-amyloid plaques may help diagnose AD earlier

Use of a new drug to detect the beta-amyloid plaques in the brain that are hallmark signs of Alzheimer's disease may help doctors diagnose the disease earlier, according to research that will be presented as part of the Emerging Science program (formerly known as Late-Breaking Science) at the American Academy of Neurology's 64th Annual Meeting in New Orleans April 21 to April 28, 2012.

16 Apr 2012

Neurological symptoms due to a bump on the head should not be ignored

When Dr. Irene Gatti de Leon slipped on the ice and bumped her head, she wasn't too concerned. But two months later, she began to experience weakness in her right leg and right arm while she and her husband were visiting their daughter in suburban Chicago.

16 Apr 2012

New genes may explain individual differences in brain size and intelligence

In the world's largest brain study to date, a team of more than 200 scientists from 100 institutions worldwide collaborated to map the human genes that boost or sabotage the brain's resistance to a variety of mental illnesses and Alzheimer's disease.

16 Apr 2012

Roundup: Texas considers relaxing rules for stem cell treatments; States weigh bills to protect consumers against high drug costs

A Texas agency will vote Friday on whether to enact new rules that would make it easier for doctors to offer experimental treatments using adult stem cells without federal approval. The Texas Medical Board, which licenses and disciplines doctors in the state, recently drafted stem-cell rules at the behest of Dr. Stanley Jones of Houston, who in July injected Gov. Rick Perry with the governor's own stem cells to try to aid his recovery from a back injury.

16 Apr 2012

Newer antidepressant decreases depression in Parkinson's patients without worsening motor problems

Certain antidepressants appear to decrease depression in people with Parkinson's disease without worsening motor problems, according to a study published in the April 11, 2012, online issue of Neurology, the medical journal of the American Academy of Neurology.

12 Apr 2012

Four abstracts on spatial neglect to be presented at upcoming AAN meeting

Anna M. Barrett, MD will represent Kessler Foundation's Stroke Rehabilitation Research Laboratory at the upcoming American Academy of Neurology Conference at the Ernest N. Morial Convention Center in New Orleans, LA, April 21 - April 28.

12 Apr 2012

Biogen Idec launches FAMPYRA in Canada

Today, Biogen Idec Canada announces that FAMPYRA (fampridine sustained release tablets or fampridine SR) is now available for prescription for patients living with multiple sclerosis (MS) in Canada.

12 Apr 2012

New 4th Edition of Practical Neurology for clinicians, residents and fellows

The new 4th Edition of Practical Neurology, the respected "real-life" guide to diagnosing and managing neurologic disorders, has been completely rewritten to known neurologist and chair of the Department of Neurology of Loyola University Chicago Stritch School of Medicine.

11 Apr 2012

New method for direct identification of antigens

The immune system is a vital part of our defenses against pathogens, but it can also attack host tissues, resulting in autoimmune disease. The antigens that induce destructive immune reactions can now be identified directly - without any prior knowledge of their possible structure.

11 Apr 2012

Reprogramming the Brain to Health Symposium to take place on April 12

Jordan Grafman, PhD, will speak at the Reprogramming the Brain to Health Symposium at The University of Texas at Dallas on April 12. An expert on brain function and behavior, Dr. Grafman's topic is human belief systems in the brain.

10 Apr 2012

Bioness commences StimRouter Neuromodulation System study for chronic peripheral nerve pain

Bioness Inc. today announced the initiation of a study to evaluate the safety and effectiveness of the company's StimRouter Neuromodulation System for those suffering from chronic peripheral nerve pain. This prospective, multi-center, randomized, double-blinded, partial crossover study will enroll 126 patients at up to 10 study sites throughout the United States.

9 Apr 2012

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Interferon beta-1a shows promise against MS

Clinical study to evaluate high-dose vitamin D supplements for MS

SBU to advance research and clinical care at National Pediatric MS Center

Abbott reports positive results from LCIG Phase 3 trial for advanced Parkinson's disease

Levodopa-carbidopa intestinal gel better than standard oral form to treat advanced Parkinson's disease

Medgenics seeks IND approval to initiate EPODURE Biopump Phase IIb anemia study in ESRD patients

ONO-4641 reduces number of lesions in people with MS

Synthon receives tentative approval for tadalafil tablets

TGF-β molecule ramps up the immune system in some cases and suppress it in others

New drug to detect beta-amyloid plaques may help diagnose AD earlier

Neurological symptoms due to a bump on the head should not be ignored

New genes may explain individual differences in brain size and intelligence

Roundup: Texas considers relaxing rules for stem cell treatments; States weigh bills to protect consumers against high drug costs

Newer antidepressant decreases depression in Parkinson's patients without worsening motor problems

Four abstracts on spatial neglect to be presented at upcoming AAN meeting

Biogen Idec launches FAMPYRA in Canada

New 4th Edition of Practical Neurology for clinicians, residents and fellows

New method for direct identification of antigens

Reprogramming the Brain to Health Symposium to take place on April 12

Bioness commences StimRouter Neuromodulation System study for chronic peripheral nerve pain

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in